Arvinas, Inc. (ARVN) financial statements (2021 and earlier)

Company profile

Business Address 395 WINCHESTER AVE
NEW HAVEN, CT 06511
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments689281188
Cash and cash equivalents58893
Short-term investments100272185
Receivables865
Other undisclosed current assets643
Total current assets:703291196
Noncurrent Assets
Operating lease, right-of-use asset22
Property, plant and equipment1284
Deposits noncurrent assets  0
Other noncurrent assets00 
Total noncurrent assets:14114
TOTAL ASSETS:717302199
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26127
Accounts payable753
Accrued liabilities1984
Deferred revenue2220
Debt 10
Contract with customer, liability16
Other undisclosed current liabilities1  
Total current liabilities:493323
Noncurrent Liabilities
Long-term debt and lease obligation342
Long-term debt, excluding current maturities222
Operating lease, liability12
Liabilities, other than long-term debt233838
Deferred revenue2338
Contract with customer, liability37
Other liabilities  0
Total noncurrent liabilities:264240
Total liabilities:757563
Stockholders' equity
Stockholders' equity attributable to parent642227137
Common stock000
Additional paid in capital1,134599439
Accumulated other comprehensive income (loss)10(0)
Accumulated deficit(492)(373)(302)
Total stockholders' equity:642227137
TOTAL LIABILITIES AND EQUITY:717302199

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Gross profit:224314
Operating expenses(147)(95)(58)
Operating loss:(125)(52)(44)
Nonoperating income662
Investment income, nonoperating452
Other nonoperating income210
Interest and debt expense(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(119)(46)(42)
Loss from equity method investments (25) 
Loss before gain (loss) on sale of properties:(119)(70)(42)
Other undisclosed net income000
Net loss attributable to parent:(119)(70)(41)
Preferred stock dividends and other adjustments  (198)
Net loss available to common stockholders, diluted:(119)(70)(240)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(119)(70)(41)
Comprehensive loss:(119)(70)(41)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)
Comprehensive loss, net of tax, attributable to parent:(119)(70)(42)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: